Literature DB >> 7616255

Mössbauer spectroscopic studies of purified human neuromelanin isolated from the substantia nigra.

M Gerlach1, A X Trautwein, L Zecca, M B Youdim, P Riederer.   

Abstract

57Fe Mössbauer spectroscopy at different temperatures has been used to characterize the nature of purified human neuromelanin isolated from the substantia nigra. The quantitative determination of iron(III) by estimation of the overall area of the Mössbauer spectrum at room temperature reveals an iron content of 2.8 +/- 1.4%. No subspectra corresponding to divalent iron could be observed in these spectra. The derived Mössbauer parameters lead to the conclusion that the iron sites in the human neuromelanin are similar to those of human hemosiderin (or ferritin). However, owing to the water insolubility of the purified neuromelanin, it must be concluded that the neuromelanin hemosiderin (or ferritin) is bound in a protein matrix that makes it insoluble and difficult to stain histochemically. This protein attachment to neuromelanin is important in that it is what makes it different from synthetic dopamine melanin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7616255     DOI: 10.1046/j.1471-4159.1995.65020923.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  24 in total

Review 1.  The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease.

Authors:  K A Jellinger
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

Review 2.  Is neuromelanin changed in Parkinson's disease? Investigations by magnetic spectroscopies.

Authors:  M Fasano; B Bergamasco; L Lopiano
Journal:  J Neural Transm (Vienna)       Date:  2006-05-12       Impact factor: 3.575

Review 3.  Subcellular proteomics reveals neuromelanin granules to be a lysosome-related organelle.

Authors:  F Tribl; K Marcus; H E Meyer; G Bringmann; M Gerlach; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  2006-05-05       Impact factor: 3.575

4.  Identification of L-ferritin in neuromelanin granules of the human substantia nigra: a targeted proteomics approach.

Authors:  Florian Tribl; Esther Asan; Thomas Arzberger; Thomas Tatschner; Elmar Langenfeld; Helmut E Meyer; Gerhard Bringmann; Peter Riederer; Manfred Gerlach; Katrin Marcus
Journal:  Mol Cell Proteomics       Date:  2009-03-24       Impact factor: 5.911

Review 5.  Neuromelanin of the human substantia nigra: an update.

Authors:  Fabio A Zucca; Emy Basso; Francesca A Cupaioli; Emanuele Ferrari; David Sulzer; Luigi Casella; Luigi Zecca
Journal:  Neurotox Res       Date:  2013-10-24       Impact factor: 3.911

6.  Changing iron content of the mouse brain during development.

Authors:  Gregory P Holmes-Hampton; Mrinmoy Chakrabarti; Allison L Cockrell; Sean P McCormick; Louise C Abbott; Lora S Lindahl; Paul A Lindahl
Journal:  Metallomics       Date:  2012-07-19       Impact factor: 4.526

7.  A reappraisal of Fe(III) adsorption by melanin.

Authors:  Rhiannon Lee Schroeder; Jacobus Petrus Gerber
Journal:  J Neural Transm (Vienna)       Date:  2014-05-21       Impact factor: 3.575

8.  X-ray absorption fine-structure spectroscopy studies of Fe sites in natural human neuromelanin and synthetic analogues.

Authors:  A J Kropf; B A Bunker; M Eisner; S C Moss; L Zecca; A Stroppolo; P R Crippa
Journal:  Biophys J       Date:  1998-12       Impact factor: 4.033

9.  GC/MS analysis of thermally degraded neuromelanin from the human substantia nigra.

Authors:  Anna Dzierzega-Lecznar; Slawomir Kurkiewicz; Krystyna Stepien; Ewa Chodurek; Tadeusz Wilczok; Thomas Arzberger; Peter Riederer; Manfred Gerlach
Journal:  J Am Soc Mass Spectrom       Date:  2004-06       Impact factor: 3.109

10.  A purple acidophilic di-ferric DNA ligase from Ferroplasma.

Authors:  Manuel Ferrer; Olga V Golyshina; Ana Beloqui; Lars H Böttger; José M Andreu; Julio Polaina; Antonio L De Lacey; Alfred X Trautwein; Kenneth N Timmis; Peter N Golyshin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.